Antibiotic treatment of bacterial meningitis;Antibiothérapie des méningites bactériennes

Revue du Praticien

Volumn 54, Issue 9, 2004, Pages 963-967

  Stahl, Jean Paul ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; GENTAMICIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; BACTERIAL MENINGITIS; DRUG CHOICE; DRUG EFFICACY; EPIDEMIC MENINGITIS; HAEMOPHILUS INFLUENZAE; HUMAN; LISTERIA; NEISSERIA MENINGITIDIS; PATIENT MONITORING; PRACTICE GUIDELINE; REVIEW; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; HUMANS; MENINGITIS, BACTERIAL;

EID: 2942707874     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Stahl JP, Decazes JM, Auvergnat JC. Apport des modèles expérimentaux au traitement des méningites bactériennes. Med Mal Infect 1984; 14: 51-5.
2. Dabernat H, Stahl JP, Goulet V et le groupe d'étude de la LFPMI. Méningites bactériennes en France. Étude dans six départements métropolitains en 1995-1997. Med Mal Infect 2000; 30: 688-94.
3. Antignac A, Ducos-Galand M, Guiyoule A, Pirès R, Alonso JM, Taha MK. Neisseria meningitidis strains isolated from invasive infections in France (1999-2002): phenotypes and antibiotic susceptibility patterns. Clin Infect Dis 2003; 37: 912-20.
4. Vogelman B, Gudmundsson S, Leggett J, Turnidge J, Ebert S, Craig WA. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J Infect Dis 1988; 158: 831-47.
5. Dajani AS, Pokowski LH. Delayed cerebrospinal fluid sterilization, in vitro bactericidal activities, and side effects of selected beta-lactams. Scand J Infect Dis 1990; 73: 31-42.
6. Leverve X, Stahl JP, Gaillat J et al. Surdosage d'amoxicilline dans le liquide céphalo-rachidien au cours du traitement des méningites purulentes. Med Mal Infect 1983; 13: 737-40.
7. Martinez-Lacasa J, Cabellos C, Martos A et al. Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis. J Antimicrob Agents 2002; 49: 507-13.
8. Brinquin L, Rousseau JM, Boulesteix G, Diraison Y, Bonsignour JP. Vancomycine en perfusion continue dans les méningites à staphylocoques postneurochirurgicales de l'adulte. Presse Med 1993; 22: 1815-7.
9. Van der Flier M, Geelen SPM, Kimpen JLL, Hoepelman IM, Tuomanen EI. Reprogramming the host response in bacterial meningitis: how best to improve outcome? Clin Microbiol Rev 2003; 16: 415-29.
10. Williams MA, Razumovsky AYe. Cerebrospinal fluid circulation, cerebral oedema and intracranial pressure. Curr Opin Neurol 1993; 6: 847-53.
11. Aronin SI, Peduzzi P, Quagilarello VJ. Community acquired bacterial meningitis: risk, stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 1998; 129: 862-9.
12. Wolff M, Auburtin M. Traitement des méningites bactériennes communautaires de l'adulte. Lettre Infect 2002; 17: 107-12.
13. Anonyme (CMIT). Les méningites. In: Pilly E (ed.). Montmorency: 2M2, 2004: 270-9.
14. Anonyme (SPILF). Les méningites purulentes communautaires (texte long). Med Mal Infect 1996; 26: 952-73.
15. Ellis-Pelgler R. Three days of intravenous benzylpenicillin treatment of meningococcal disease in adults. Clin Infect Dis 2003; 37: 658-62.
16. Quagliarello V, Sheld WM. Bacterial meningitis: pathogenesis, pathophysiology and progress. N Engl J Med 1992; 327: 864-72.
17. Saez-Lhorens X, McCraken GH. Bacterial meningitis in children. Lancet 2003; 361: 2139-48.